<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
10 Q FOR THE PERIOD ENDED JUNE 30, 2000
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 10,704
<SECURITIES> 7,824<F1>
<RECEIVABLES> 490
<ALLOWANCES> 0
<INVENTORY> 1,150
<CURRENT-ASSETS> 19,081
<PP&E> 2,390<F2>
<DEPRECIATION> 0
<TOTAL-ASSETS> 23,914
<CURRENT-LIABILITIES> 1,755
<BONDS> 0
0
0
<COMMON> 12
<OTHER-SE> 21,849
<TOTAL-LIABILITY-AND-EQUITY> 23,914
<SALES> 1,760
<TOTAL-REVENUES> 1,760
<CGS> 2,289
<TOTAL-COSTS> 2,289
<OTHER-EXPENSES> 6,181<F3>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 10
<INCOME-PRETAX> (6,380)
<INCOME-TAX> 0
<INCOME-CONTINUING> (6,380)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,380)
<EPS-BASIC> (0.63)<F4>
<EPS-DILUTED> (0.63)
<FN>
<F1>Securities, Item 5-02(2), are net of accrued interest and unrealized gain/loss.
<F2>PP&E, Item 5-02(13), shown net of accumulated depreciation.
<F3>Other Expenses, Item 5-03(b)3, consists of research and development costs.
<F4>EPS Basic, Item 5-03(b)(20), consists of basic earnings per share.
</FN>
</TABLE>